Cholangiocarcinoma+1
Not yet recruitingSafety and feasibility study of hepatic arterial vs IV oxaliplatin in patients with colorectal liver metastases and cholangiocarcinoma (oxaliplatin drug combination)
Safety and feasibility study of hepatic arterial vs IV oxaliplatin in patients with colorectal liver metastases and cholangiocarcinoma (oxaliplatin drug combination)
- Disease:CholangiocarcinomaMetastases to liver
- Substances:CapecitabineHeparin Sodium+3
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Capecitabine
- Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
